Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on August 10, 2005
J Am Soc Nephrol 16: 2997-3005, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005020137

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005020137v1
16/10/2997    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eto, N.
Right arrow Articles by Nangaku, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eto, N.
Right arrow Articles by Nangaku, M.

Pathophysiology of Renal Disease and Progression

Protection of Endothelial Cells by Dextran Sulfate in Rats with Thrombotic Microangiopathy

Nobuaki Eto*, Ichiro Kojima*, Noriko Uesugi{dagger}, Reiko Inagi{ddagger}, Toshio Miyata{ddagger}, Toshiro Fujita*, Richard J. Johnson§, Stuart J. Shankland|| and Masaomi Nangaku*

* Division of Nephrology and Endocrinology, University of Tokyo, School of Medicine, Tokyo, Japan; {dagger} Department of Pathology, Fukuoka University, School of Medicine, Fukuoka, Japan; {ddagger} Molecular and Cellular Nephrology, Institute of Medical Sciences, Tokai University, Kanagawa, Japan; § Division of Nephrology, Hypertension, and Transplantation, University of Florida, Gainesville, Florida; and || Division of Nephrology, University of Washington, Seattle, Washington

Address correspondence to: Dr. Masaomi Nangaku, Division of Nephrology and Endocrinology, University of Tokyo, School of Medicine, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655 Japan. Phone: 81-3-5800-8648; Fax: 81-3-5800-8806; E-mail: mnangaku-tky{at}umin.ac.jp

Received for publication February 4, 2005. Accepted for publication July 4, 2005.

The characteristic features of thrombotic microangiopathy (TMA) include glomerular and peritubular capillary endothelial cell injury in association with loss of heparan sulfate proteoglycans on the cell surface and thrombus formation, followed by subsequent ischemic tubulointerstitial damage. It therefore was hypothesized that dextran sulfate (DXS) may protect the kidney against endothelial damage in a model of TMA. TMA was induced in rats by renal artery perfusion of an antiglomerular endothelial antibody, followed by the administration of DXS or vehicle. Renal damage was assessed by histologic analysis and measurements of blood urea nitrogen and creatinine. Whereas control rats developed severe renal failure with extensive glomerular and tubular injury, administration of DXS significantly protected renal function and preserved the glomerular endothelium and peritubular capillaries. The beneficial effect of DXS could be attributed to the ability of DXS to protect endothelial cells from coagulation and complement activation, as demonstrated by the histologic analysis. In addition, binding of the administered DXS to the surface of the glomerular endothelium was confirmed in TMA rats, suggesting that DXS acts as a "repair coat" of injured glomerular endothelium. In conclusion, DXS protects the kidney from experimental TMA. This protection may be mediated by DXS’s binding directly to the surface of glomerular endothelium and amelioration of coagulation, complement activation, and cellular matrix loss.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. Inagi, T. Kumagai, H. Nishi, T. Kawakami, T. Miyata, T. Fujita, and M. Nangaku
Preconditioning with Endoplasmic Reticulum Stress Ameliorates Mesangioproliferative Glomerulonephritis
J. Am. Soc. Nephrol., May 1, 2008; 19(5): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Nangaku
Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 17 - 25.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP